These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26691655)

  • 21. Native pancreatic alpha-cell adaptation in streptozotocin-induced diabetic primates: importance for pig islet xenotransplantation.
    Dufrane D; Maillart JF; Aouassar N; Goebbels RM; Guiot Y; Gianello P
    Xenotransplantation; 2009; 16(3):152-63. PubMed ID: 19566655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
    Meneghini L; Koenen C; Weng W; Selam JL
    Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
    Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology of intravenous insulin administration: implications for future closed-loop glycemic control by the intravenous/intravenous route.
    Skjaervold NK; Lyng O; Spigset O; Aadahl P
    Diabetes Technol Ther; 2012 Jan; 14(1):23-9. PubMed ID: 21751892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic rats and mice are resistant to porcine and human insulin: flawed experimental models for testing islet xenografts.
    Pepper AR; Gall C; Mazzuca DM; Melling CW; White DJ
    Xenotransplantation; 2009; 16(6):502-10. PubMed ID: 20042050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of diabetic ketoacidosis secondary to fulminant type 1 diabetes mellitus using a closed-loop artificial pancreas in a pediatric patient.
    Tamura T; Tadokoro T; Iwata H; Namikawa T; Hanazaki K; Kawano T
    J Artif Organs; 2024 Mar; 27(1):73-76. PubMed ID: 36512306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of the timing of Humalog Mix25 injections on blood glucose fluctuations in the postprandial period in elderly patients with type 2 diabetes.
    Galic E; Vrtovec M; Bozikov V; Schwarzenhofer M; Milicevic Z
    Med Sci Monit; 2005 Dec; 11(12):PI87-92. PubMed ID: 16319804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neural network-based model predictive control for type 1 diabetic rats on artificial pancreas system.
    Bahremand S; Ko HS; Balouchzadeh R; Felix Lee H; Park S; Kwon G
    Med Biol Eng Comput; 2019 Jan; 57(1):177-191. PubMed ID: 30069675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system.
    Renard E; Costalat G; Chevassus H; Bringer J
    Diabetes Metab; 2006 Dec; 32(5 Pt 2):497-502. PubMed ID: 17130808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: a prospective randomized clinical trial.
    Okabayashi T; Nishimori I; Yamashita K; Sugimoto T; Maeda H; Yatabe T; Kohsaki T; Kobayashi M; Hanazaki K
    Arch Surg; 2009 Oct; 144(10):933-7. PubMed ID: 19841361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automatic bolus and adaptive basal algorithm for the artificial pancreatic β-cell.
    Wang Y; Dassau E; Zisser H; Jovanovič L; Doyle FJ
    Diabetes Technol Ther; 2010 Nov; 12(11):879-87. PubMed ID: 20879966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
    Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
    Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis.
    Nimri R; Muller I; Atlas E; Miller S; Kordonouri O; Bratina N; Tsioli C; Stefanija MA; Danne T; Battelino T; Phillip M
    Pediatr Diabetes; 2014 Mar; 15(2):91-9. PubMed ID: 23944875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid restoration of normoglycaemia using intravenous insulin boluses.
    Dunnett JM; Steemson J; Sear JW; Turner RC; Holman RR
    Diabetes Res; 1990 Dec; 15(4):151-5. PubMed ID: 2132403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo study of a polymeric glucose-sensitive insulin delivery system using a rat model.
    Taylor MJ; Tanna S; Sahota T
    J Pharm Sci; 2010 Oct; 99(10):4215-27. PubMed ID: 20737629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
    Ritsinger V; Malmberg K; Mårtensson A; Rydén L; Wedel H; Norhammar A
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smart approaches to glucose-responsive drug delivery.
    Webber MJ; Anderson DG
    J Drug Target; 2015; 23(7-8):651-5. PubMed ID: 26453161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous bolus insulin delivery: implications for closed-loop control and hospital care.
    Hirsch IB
    Diabetes Technol Ther; 2012 Jan; 14(1):6-7. PubMed ID: 21992271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.